Cargando…

Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?

Hypermobile Ehlers-Danlos syndrome (hEDS) is the most frequent type of EDS and is characterized by generalized joint hypermobility and musculoskeletal manifestations which are associated with chronic pain, and mild skin involvement along with the presence of more than a few comorbid conditions. Desp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiarelli, Nicola, Zoppi, Nicoletta, Venturini, Marina, Capitanio, Daniele, Gelfi, Cecilia, Ritelli, Marco, Colombi, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621259/
https://www.ncbi.nlm.nih.gov/pubmed/34831458
http://dx.doi.org/10.3390/cells10113236
_version_ 1784605414788169728
author Chiarelli, Nicola
Zoppi, Nicoletta
Venturini, Marina
Capitanio, Daniele
Gelfi, Cecilia
Ritelli, Marco
Colombi, Marina
author_facet Chiarelli, Nicola
Zoppi, Nicoletta
Venturini, Marina
Capitanio, Daniele
Gelfi, Cecilia
Ritelli, Marco
Colombi, Marina
author_sort Chiarelli, Nicola
collection PubMed
description Hypermobile Ehlers-Danlos syndrome (hEDS) is the most frequent type of EDS and is characterized by generalized joint hypermobility and musculoskeletal manifestations which are associated with chronic pain, and mild skin involvement along with the presence of more than a few comorbid conditions. Despite numerous research efforts, no causative gene(s) or validated biomarkers have been identified and insights into the disease-causing mechanisms remain scarce. Variability in the spectrum and severity of symptoms and progression of hEDS patients’ phenotype likely depend on a combination of age, gender, lifestyle, and the probable multitude of genes involved in hEDS. However, considering the clinical overlap with other EDS forms, which lead to abnormalities in extracellular matrix (ECM), it is plausible that the mechanisms underlying hEDS pathogenesis also affect the ECM to a certain extent. Herein, we performed a series of in vitro studies on the secretome of hEDS dermal fibroblasts that revealed a matrix metalloproteinases (MMPs) dysfunction as one of the major disease drivers by causing a detrimental feedback loop of excessive ECM degradation coupled with myofibroblast differentiation. We demonstrated that doxycycline-mediated inhibition of MMPs rescues in hEDS cells a control-like ECM organization and induces a partial reversal of their myofibroblast-like features, thus offering encouraging clues for translational studies confirming MMPs as a potential therapeutic target in hEDS with the expectation to improve patients’ quality of life and alleviate their disabilities.
format Online
Article
Text
id pubmed-8621259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86212592021-11-27 Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target? Chiarelli, Nicola Zoppi, Nicoletta Venturini, Marina Capitanio, Daniele Gelfi, Cecilia Ritelli, Marco Colombi, Marina Cells Article Hypermobile Ehlers-Danlos syndrome (hEDS) is the most frequent type of EDS and is characterized by generalized joint hypermobility and musculoskeletal manifestations which are associated with chronic pain, and mild skin involvement along with the presence of more than a few comorbid conditions. Despite numerous research efforts, no causative gene(s) or validated biomarkers have been identified and insights into the disease-causing mechanisms remain scarce. Variability in the spectrum and severity of symptoms and progression of hEDS patients’ phenotype likely depend on a combination of age, gender, lifestyle, and the probable multitude of genes involved in hEDS. However, considering the clinical overlap with other EDS forms, which lead to abnormalities in extracellular matrix (ECM), it is plausible that the mechanisms underlying hEDS pathogenesis also affect the ECM to a certain extent. Herein, we performed a series of in vitro studies on the secretome of hEDS dermal fibroblasts that revealed a matrix metalloproteinases (MMPs) dysfunction as one of the major disease drivers by causing a detrimental feedback loop of excessive ECM degradation coupled with myofibroblast differentiation. We demonstrated that doxycycline-mediated inhibition of MMPs rescues in hEDS cells a control-like ECM organization and induces a partial reversal of their myofibroblast-like features, thus offering encouraging clues for translational studies confirming MMPs as a potential therapeutic target in hEDS with the expectation to improve patients’ quality of life and alleviate their disabilities. MDPI 2021-11-19 /pmc/articles/PMC8621259/ /pubmed/34831458 http://dx.doi.org/10.3390/cells10113236 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chiarelli, Nicola
Zoppi, Nicoletta
Venturini, Marina
Capitanio, Daniele
Gelfi, Cecilia
Ritelli, Marco
Colombi, Marina
Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
title Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
title_full Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
title_fullStr Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
title_full_unstemmed Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
title_short Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
title_sort matrix metalloproteinases inhibition by doxycycline rescues extracellular matrix organization and partly reverts myofibroblast differentiation in hypermobile ehlers-danlos syndrome dermal fibroblasts: a potential therapeutic target?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621259/
https://www.ncbi.nlm.nih.gov/pubmed/34831458
http://dx.doi.org/10.3390/cells10113236
work_keys_str_mv AT chiarellinicola matrixmetalloproteinasesinhibitionbydoxycyclinerescuesextracellularmatrixorganizationandpartlyrevertsmyofibroblastdifferentiationinhypermobileehlersdanlossyndromedermalfibroblastsapotentialtherapeutictarget
AT zoppinicoletta matrixmetalloproteinasesinhibitionbydoxycyclinerescuesextracellularmatrixorganizationandpartlyrevertsmyofibroblastdifferentiationinhypermobileehlersdanlossyndromedermalfibroblastsapotentialtherapeutictarget
AT venturinimarina matrixmetalloproteinasesinhibitionbydoxycyclinerescuesextracellularmatrixorganizationandpartlyrevertsmyofibroblastdifferentiationinhypermobileehlersdanlossyndromedermalfibroblastsapotentialtherapeutictarget
AT capitaniodaniele matrixmetalloproteinasesinhibitionbydoxycyclinerescuesextracellularmatrixorganizationandpartlyrevertsmyofibroblastdifferentiationinhypermobileehlersdanlossyndromedermalfibroblastsapotentialtherapeutictarget
AT gelficecilia matrixmetalloproteinasesinhibitionbydoxycyclinerescuesextracellularmatrixorganizationandpartlyrevertsmyofibroblastdifferentiationinhypermobileehlersdanlossyndromedermalfibroblastsapotentialtherapeutictarget
AT ritellimarco matrixmetalloproteinasesinhibitionbydoxycyclinerescuesextracellularmatrixorganizationandpartlyrevertsmyofibroblastdifferentiationinhypermobileehlersdanlossyndromedermalfibroblastsapotentialtherapeutictarget
AT colombimarina matrixmetalloproteinasesinhibitionbydoxycyclinerescuesextracellularmatrixorganizationandpartlyrevertsmyofibroblastdifferentiationinhypermobileehlersdanlossyndromedermalfibroblastsapotentialtherapeutictarget